Recall Roundup: tainted heparin, glass flakes, odorous bottles and more
This article was originally published in The Gold Sheet
Executive Summary
Economically motivated adulteration, glass flakes in vials, out-of-specification transdermal patches, malodorous bottles and prefilled syringe sterility were among the more significant manufacturing quality issues leading to drug recalls in the past three months.
You may also be interested in...
Poor Handling of Complaints, Contractors, Contamination Draw FDA Warning Letters
Several warning letters FDA issued in January and February highlighted complaint handling issues, supply chain considerations and contamination-related concerns.
Poor Handling of Complaints, Contractors, Contamination Draw FDA Warning Letters
Several warning letters FDA issued in January and February highlighted complaint handling issues, supply chain considerations and contamination-related concerns.